India faces the challenge of inappropriate use of antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....

The editor of The Lancet, Richard Horton, has said naming a Superbug after New Delhi was an “error”, and has apologised. Some Europeans returning from South Asia had been found infected with a bacteria carrying a drug-resistant gene last year, which had been named New Delhi metallo-beta-lactamase, or NDM-1, as the first patient had flown from Delhi to Sweden with the infection. While acknowledging this was a mistake, Horton said, “the science...

After creating a huge controversy by claiming that foreign patients who were treated in India developed antibiotic resistance, authors of the Superbug New Delhi metallo-B-lactamase-1 (NDM-1) bacteria study published in the United Kingdom-based medical journal The Lancet now say that poor sanitation and unregulated antibiotic use presented an immense challenge and should be of great concern to the Indian health authorities and the World Health Organisation. Responding to queries in the...

Lancet dismisses criticisms levelled at the “rural MBBS,” saying they bear little credibility The Union Health and Family Welfare Ministry might still be awaiting “formal” clearance for its much debated Bachelor of Rural Health Care course that aims to create a cadre of healthcare workers for the rural areas, but the Centre has received global appreciation for “trying to find an innovative solution to a deeply entrenched problem which is not...